AstraZeneca - the company collaborating with Oxford University on a coronavirus vaccine - is set to run an extra trial of the jab.
Full ArticleAstraZeneca to run extra trial of COVID vaccine developed with Oxford University
Sky News
0 shares
1 views
You might like
Related news coverage
Moderna boss says its COVID-19 vaccine should be given to vulnerable
Proactive Investors
Moderna Inc (NASDAQ:MRNA) has confirmed its COVID-19 vaccine achieved a 94% success in its recent phase III trial and that it will..
-
Volunteer seeks investigation on Serum after developing complication but company is intimidating
Mid-Day
-
Serum Institute files Rs 100 crore defamation case after man says vaccine left him ill
Mid-Day
-
Man who undertook Covidshield vaccine trial alleges neurological breakdown, seeks Rs 5 crore compensation
Mid-Day
-
Thailand signs supply deals for AstraZeneca COVID-19 vaccine
SeattlePI.com
Advertisement
More coverage
Vaccine blow as Oxford Covid-19 trial to be re-run after research error
Daily Record
Pharma firm AstraZeneca which is partnering the university admitted the mistake following US reports that its best dosage only..
AstraZeneca mulls new coronavirus vaccine trial following results confusion
Proactive Investors